2 ms·
"To therapeutically influence the microbiome long-term in humans is a big hurdle," said Sander van Deventer, managing partner at venture-capital firm Forbion Ca
by Mz 11y ago
"To therapeutically influence the microbiome long-term in humans is a big hurdle," said Sander van Deventer, managing partner at venture-capital firm Forbion Capital Partners. "The microbiome is very stubborn. Everything we’ve done so far has only had a temporary effect."
I am guessing they are looking at one shot drug therapies. This is totally doable if you make dietary and lifestyle changes and are persistent. Yes, actually moving the numbers (so to speak) is tough going, but it can be done.